University of Utah
Salt Lake City, Utah, 84132, United States
NCT Number: NCT01233817
The proposed feasibility study is necessary to test if children and young adults will participate in and adhere to a 12-week, home-based, supervised progressive strength training exercise program and to obtain preliminary data that will subsequently allow us to determine the safety and impact of strength training in spinal muscular atrophy. Our pilot study will address 3 aims: (1) Ascertain the feasibility of, and potential barriers to, participation in and adherence to a 12-week home-based, supervised, progressive strength training exercise program in children and young adults aged 5-21 years with SMA types II and III; (2) Determine the safety and tolerability of progressive strength training in a pilot study sample of children and young adults with SMA types II and III; and (3) Determine candidate outcome measures.
Looking for future studies?
Notify Me5 year–21 year
All sexes
Interventional
Not applicable
Salt Lake City, Utah, 84132, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
the systematic increase in resistance weights
Time frame: 12 weeks
Primary Outcome Measure was muscle strength. Strength was measured using a fixed myometry evaluation, quantitative muscle analysis (QMA). QMA utilizes a relative fixed point for the participant to exert effort. Each muscle of interest was tested using QMA.
University of Utah
Other
Pilot Study of Progressive Strength Training in Spinal Muscular Atrophy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05156320
Anti-myostatin, Atrophy
Birmingham, Alabama, United States
View Trial DetailsNCT03921528
Atrophy, Central Nervous System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05626855
Anti-myostatin, Atrophy
Phoenix, Arizona, United States
View Trial DetailsNCT05808764
Central Nervous System Diseases, Motor Neuron Disease
Chicago, Illinois, United States
View Trial Details